Preview of RheumNow Live 2026 Save
Drs. Jack Cush and Artie Kavanaugh preview the upcoming RNL 2026 meeting in Dallas, TX on February 7 & 8, 2026. Register at RheumNow.Live Below is the program: Saturday, February 7, 2026, 7:50 - 8:00 am Welcome & Introductions Drs. Cush and Kavanaugh 8:00 - 10:00 am POD I - Rheumatoid Arthritis: Achieving Better Outcomes 8:00 – 8:30 am Mortality in RA: A Story of Decline, Delay, or Plateau? Elena Myasoedova, MD 8:30 – 9:00 am The Mucosal Hypothesis of Rheumatoid Arthritis Kristen Demoruelle, MD 9:00 – 9:30 am ILD in RA – Recent Advances Jeffrey Sparks, MD 9:30 – 10:00 am Rheumatoid arthritis Faculty Q&A 10:00 - 10:15 am STEP 1: Placebos in Rheumatology Andreas Kerschbaumer, MD 10:15 -10:30 am STEP 2: Disease Modification in Osteoarthritis Tuhina Neogi, MD PhD 10:30 – 11:05 Break 11:05 - 12:10 pm POD II – Advancing Practice 11:05 – 11:30 am Obesity & Inflammation: Weight Management in Rheumatology Uzma Haque, MD 11:30 - 11:55 am Mitigating risk in Rheum Pts undergoing surgery Susan Goodman, MD 11:55 -12:10 pm Practice Panel Faculty Q&A 12:10 – 1:00pm Lunch 1:00 – 3:00 pm POD III – Decisions in Psoriatic Arthritis 1:00 - 1:30 pm Paradoxical Psoriasis and Strange Reactions Joseph Merola, MD 1:30 - 2:00 pm Why Do Plain X rays in Psoriatic Arthritis Arthur Kavanaugh, MD 2:00 - 2:30 pm IL-23 vs IL-17 inhibitors in PsA Andre Ribero, MD 2:30 - 3:00 pm Past, Present & Future of Gout Robert Terkeltaub, MD 3:00 - 3:30 pm Psoriatic Faculty Q&A 3:30 - 4:05 pm Break 4:05 - 4:20 pm STEP 3: Helicobacter Pylori update Byron Cryer, MD 4:20 - 4:35 pm STEP 4: History of Gout Robert Terkeltaub, MD 4:35 – 5:15 pm Keynote Address: 50 Years of Osteoporosis Michael McClung, MD 5:30 – 7:00 pm Reception Sunday, February 8, 2026 Day TOPIC Speaker 7:50-8:00 am Welcome & Introductions Drs. Cush and Kavanaugh 8:00 - 10:00 am POD IV – Staying Ahead of Spondyloarthritis 8:00 – 8:30 am Diagnosing Axial Spondyloarthritis in 2026 Denis Poddubnyy, MD 8:30 – 9:00 am Spondyloarthritis Complications Jessica Walsh, MD 9:00 – 9:30 am 2026 Advances in Spondyloarthritis Catherine Bakewell, MD 9:30 – 10:00 am Spondyloarthritis Faculty Q&A 10:00 – 10:15 am STEP 5: Asymptomatic Elevation of CK Rojit Agarwal, MD MS 10:15 – 10:30 am STEP 6: Update on Myositis Antibodies Rojit Agarwal, MD MS 10:30 – 11:05 am Break 11:05 – 12:10 am POD V – Highlights in Autoimmune Disease 11:05 - 11:35 am SMILE Study – Hydroxychloroquine in ANA+ Arthralgia Nancy Olsen, MD 11:35 – 12:05 am Sjogren's Treatment Landscape in 2026 Matthew Baker, MD 12:05 - 12:20 pm Autoimmune Faculty Q&A 12:20 – 1:25 pm POD VI - Large & Small Vessel Vasculitis 12:20 – 12:45 pm Embracing Relapses in PMR and GCA Michael Putman, MD 12:45 - 1:10 pm Small vessel vasculitis Clay Cockerell, MD 1:10 - 1:25 pm Vasculitis Faculty Q&A 1:30 pm Adjourn
Transcription
Hello, everyone. Welcome to a preview of RheumNow Live twenty twenty six. I'm Jack Cush in Dallas, Texas.
Artie Cavanaugh, San Diego.
Artie, we're looking forward to another meeting. This is our eighth year of a truly unique hybrid meeting, both live on-site in Dallas and online and virtual for those around the world who won't make the trip that they should make to come to Dallas. Again, the meeting keeps getting better and better. The distinctive features of RheumNow live are evident to all those who've attended. Short sessions, highly interactive, more discussions.
It it's really quite a meeting, and we're here to tell you about the things that we think are distinctive.
Yeah. It's cutting edge as it always is. And that means that the topics that you're gonna see, either remote or live, are gonna be up to date, really thought provoking and important to help you take care of the patients. And for those of you who get to come in person, get to interact with their colleagues. And that's really a highlight for how all of us learn.
Yeah. And as we put this meeting together and talk to our colleagues about what's hot and who's great and who needs stage time, We've got a lot of new things on the program that I'm really kinda excited about. We have two lectures on myositis from Rohit Agarwal. We have Tahina Nioji from Boston talking about disease modification and osteoarthritis. Susan Goodman from HSS talking about perioperative management of RA patients.
And Usma Haq from Johns Hopkins is gonna talk about weight management and how it's important in managing this problem of obesity and inflammation. Arty, what sessions are you looking forward to?
Well, I think one of the unique parts of RoomNow Live has always been that you have your perhaps more typical educational session. So the one on rheumatoid arthritis, very strong this year with Elena Mayasadova looking at mortality over time, the mucosal hypothesis of RA with Kirsten Demarell, and then an update on interstitial lung disease with Jeff Spark. So super hot topics that are, you know, just the we we need to know about them, and these are the best people to give us up to date reports of what's going on.
You know, what I like about that is on each of those topics, those are the three people, you know, about mortality and RA. Who knows better than, Elena and the Mayo Clinic? You know, on ILD and lung, who knows better than than Jeff? You know, he's the master. And, you know, Kristen Demarell comes from the University of Colorado where she works in a division that had been devoted to this at risk disease preclinical RA, and they developed this mucosal hypothesis stuff.
I think this is really cool for covering RA.
Yeah, and I think another part of RheumNow live that's really distinctive is to the step talks in particular, you mentioned a couple of them. These are scientific sessions to be sure, but they're a little different. It's not just like a lecture on this disease or this aspect of the disease. And I'm thinking of a couple of them in particular. We have Bob Turkletub, who I always like to say he was gout before gout was cool.
And he's going to weave in the historical aspects and then talk to us really about the science and the development and where newer therapies are gonna go. Also Mike McClung, who has been in osteoporosis forever, before it was even a thing. He's been there watching that develop. There too, he's right on the key of the most advanced science, but also puts in a historical perspective that makes us really that much more understandable and just really fun.
Yeah, the spondylitis section looks really, really good. Dennis Podovny is gonna talk about new ways of thinking about the diagnosis of spondyloarthritis, that's and gonna be followed up by sort of a tandem lecture, just like Arty and I have done doing rheumatology roundup. We're gonna have, doctors Jessica Walsh and Catherine Bakewell, colleagues, friends, life lifelong sort of investigators and researchers and teachers, they're gonna be on stage together talking about, either what's new in treatment or in the in in advances and complications. They're gonna surprise us by doing this tandem presentation for about an hour on stage. I'm really looking forward to that.
I think it's a nice balance with Dennis, know, is more of the rigorous, you know, the research approach to the disease, and he's going to talk about really keeping up with the classification criteria. And then Jessica and Catherine are fabulous, and they will talk about it, but definitely grounded in a clinical basis, which is what we really need to know as we take care of patients.
Yeah, so other hot topics, H. Pylori, Sjogren's syndrome from Matt Baker from Stanford, Nancy Olsen talking about hydroxychloroquine and ANA positive arthralgia. That's been a big study that just got published. And then we have a session that's gonna end on vasculitis that looks cool as well. So these are, I think really interesting things.
The things that I think are really interesting is who's gonna be teaching you either online or before you come.
Yeah. Yeah. Mike Putnam has been running the pre learning for those of you who already signed up, and and will continue to do so and making that fun and interesting. And Janet Pope will be riding her on the online and the virtual aspect of the meeting, which is important, and we'd love everybody to come, but we know people, not everybody is able to come every year in person. So this gives a way to participate in the meeting, and by having Janet run it's not just a sit home, watch a Zoom meeting.
It's really more integrated and more personal.
What's great about RheumNow Live is it's a day and a half meeting over the weekend. It's an easy travel to Dallas. You're eight minutes from the airport. The hotel is fabulous with a lot to do right around it. You'll if you're on-site, you'll be able to rub elbows.
We have all of our speakers are gonna be on-site. That's gonna be really, really cool. And then after the lectures, great interactions during the breaks. But more importantly, we have a really nice evening reception when you arrive on Friday night and also on Saturday night, or you can be on your own. So that looks really, really good.
So again, if you want to register, now is the time because the early bird registration period ends December 15. So you can get in at a lower price and make this quite affordable. Go to room now. Live to register. And then right RDR meetings on the seventh and eighth in Dallas and then a day or two after, we're gonna get back on a plane and go where?
Going to Rheumatology Winter Clinical Symposium. That starts Wednesday, February 11 in Maui. Many of you have been there, many of you have enjoyed that, and we'd certainly welcome you back. Jack and I will be there. It's a and it'll be also just a a solid program, and we hope to have you attend both.
Yeah. It is it's quite an experience. And then if you can make that one too, I I would highly recommend it. Artie, thanks for doing this preview. We'll see everyone in Dallas on February or in Maui on February.
Take
care. Both.
Right. Why not?
Artie Cavanaugh, San Diego.
Artie, we're looking forward to another meeting. This is our eighth year of a truly unique hybrid meeting, both live on-site in Dallas and online and virtual for those around the world who won't make the trip that they should make to come to Dallas. Again, the meeting keeps getting better and better. The distinctive features of RheumNow live are evident to all those who've attended. Short sessions, highly interactive, more discussions.
It it's really quite a meeting, and we're here to tell you about the things that we think are distinctive.
Yeah. It's cutting edge as it always is. And that means that the topics that you're gonna see, either remote or live, are gonna be up to date, really thought provoking and important to help you take care of the patients. And for those of you who get to come in person, get to interact with their colleagues. And that's really a highlight for how all of us learn.
Yeah. And as we put this meeting together and talk to our colleagues about what's hot and who's great and who needs stage time, We've got a lot of new things on the program that I'm really kinda excited about. We have two lectures on myositis from Rohit Agarwal. We have Tahina Nioji from Boston talking about disease modification and osteoarthritis. Susan Goodman from HSS talking about perioperative management of RA patients.
And Usma Haq from Johns Hopkins is gonna talk about weight management and how it's important in managing this problem of obesity and inflammation. Arty, what sessions are you looking forward to?
Well, I think one of the unique parts of RoomNow Live has always been that you have your perhaps more typical educational session. So the one on rheumatoid arthritis, very strong this year with Elena Mayasadova looking at mortality over time, the mucosal hypothesis of RA with Kirsten Demarell, and then an update on interstitial lung disease with Jeff Spark. So super hot topics that are, you know, just the we we need to know about them, and these are the best people to give us up to date reports of what's going on.
You know, what I like about that is on each of those topics, those are the three people, you know, about mortality and RA. Who knows better than, Elena and the Mayo Clinic? You know, on ILD and lung, who knows better than than Jeff? You know, he's the master. And, you know, Kristen Demarell comes from the University of Colorado where she works in a division that had been devoted to this at risk disease preclinical RA, and they developed this mucosal hypothesis stuff.
I think this is really cool for covering RA.
Yeah, and I think another part of RheumNow live that's really distinctive is to the step talks in particular, you mentioned a couple of them. These are scientific sessions to be sure, but they're a little different. It's not just like a lecture on this disease or this aspect of the disease. And I'm thinking of a couple of them in particular. We have Bob Turkletub, who I always like to say he was gout before gout was cool.
And he's going to weave in the historical aspects and then talk to us really about the science and the development and where newer therapies are gonna go. Also Mike McClung, who has been in osteoporosis forever, before it was even a thing. He's been there watching that develop. There too, he's right on the key of the most advanced science, but also puts in a historical perspective that makes us really that much more understandable and just really fun.
Yeah, the spondylitis section looks really, really good. Dennis Podovny is gonna talk about new ways of thinking about the diagnosis of spondyloarthritis, that's and gonna be followed up by sort of a tandem lecture, just like Arty and I have done doing rheumatology roundup. We're gonna have, doctors Jessica Walsh and Catherine Bakewell, colleagues, friends, life lifelong sort of investigators and researchers and teachers, they're gonna be on stage together talking about, either what's new in treatment or in the in in advances and complications. They're gonna surprise us by doing this tandem presentation for about an hour on stage. I'm really looking forward to that.
I think it's a nice balance with Dennis, know, is more of the rigorous, you know, the research approach to the disease, and he's going to talk about really keeping up with the classification criteria. And then Jessica and Catherine are fabulous, and they will talk about it, but definitely grounded in a clinical basis, which is what we really need to know as we take care of patients.
Yeah, so other hot topics, H. Pylori, Sjogren's syndrome from Matt Baker from Stanford, Nancy Olsen talking about hydroxychloroquine and ANA positive arthralgia. That's been a big study that just got published. And then we have a session that's gonna end on vasculitis that looks cool as well. So these are, I think really interesting things.
The things that I think are really interesting is who's gonna be teaching you either online or before you come.
Yeah. Yeah. Mike Putnam has been running the pre learning for those of you who already signed up, and and will continue to do so and making that fun and interesting. And Janet Pope will be riding her on the online and the virtual aspect of the meeting, which is important, and we'd love everybody to come, but we know people, not everybody is able to come every year in person. So this gives a way to participate in the meeting, and by having Janet run it's not just a sit home, watch a Zoom meeting.
It's really more integrated and more personal.
What's great about RheumNow Live is it's a day and a half meeting over the weekend. It's an easy travel to Dallas. You're eight minutes from the airport. The hotel is fabulous with a lot to do right around it. You'll if you're on-site, you'll be able to rub elbows.
We have all of our speakers are gonna be on-site. That's gonna be really, really cool. And then after the lectures, great interactions during the breaks. But more importantly, we have a really nice evening reception when you arrive on Friday night and also on Saturday night, or you can be on your own. So that looks really, really good.
So again, if you want to register, now is the time because the early bird registration period ends December 15. So you can get in at a lower price and make this quite affordable. Go to room now. Live to register. And then right RDR meetings on the seventh and eighth in Dallas and then a day or two after, we're gonna get back on a plane and go where?
Going to Rheumatology Winter Clinical Symposium. That starts Wednesday, February 11 in Maui. Many of you have been there, many of you have enjoyed that, and we'd certainly welcome you back. Jack and I will be there. It's a and it'll be also just a a solid program, and we hope to have you attend both.
Yeah. It is it's quite an experience. And then if you can make that one too, I I would highly recommend it. Artie, thanks for doing this preview. We'll see everyone in Dallas on February or in Maui on February.
Take
care. Both.
Right. Why not?
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.